| Ytd | 64.40% | |
| 1y | 71.52% |
| Open | 13.00 | Prev Close | 12.79 | Low | 12.70 | High | 13.11 | Mkt Cap | 1.21B |
| Vol | 392.26K | Avg Vol | 883.76K | EPS | -1.48 | P/E | -8.83 | Forward P/E | 1.61 |
| Beta | 1.21 | Short Ratio | 4.39 | Inst. Own | 61.57% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 11.63 | 200-d Avg | 9.19 | 1yr Est | 28.38 |
MGTX News
LONDON and NEW YORK, Aug. 06, 2026 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a verti
MeiraGTx Holdings plc is positioned potentially for significant upside with late-stage gene therapy
The mean of analysts' price targets for MeiraGTx (MGTX) points to a 128.1% upside in the stock. Whil
Stuart Naylor liquidated 27,659 shares for $409,000 on July 7, 2026, at a weighted average price of
Gainers AVITA Medical (NASDAQ:RCEL) stock moved upwards by 11.1% to $4.9 during Thursday's afte
MeiraGTx (MGTX) saw its shares surge in the last session with trading volume being higher than avera
LONDON and NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a verti
MeiraGTx is evolving into a late-stage, manufacturing-enabled genetic medicine company with multiple
MeiraGTx Holdings plc (MGTX) Presents at Jefferies Global Healthcare Conference 2026 Transcript
MeiraGTx Holdings plc (MGTX) Presents at Bank of America Global Healthcare Conference 2026 Transcrip
LONDON and NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertic
MeiraGTx Holdings PLC (MGTX) came out with a quarterly loss of $0.57 per share versus the Zacks Cons
Received FDA Breakthrough Therapy Designation for AAV2-hAQP1 Reported positive three-year data from
MeiraGTx (MGTX) doesn't possess the right combination of the two key ingredients for a likely earnin
MeiraGTx (MGTX) witnessed a jump in share price last session on above-average trading volume. The la
MeiraGTx Holdings PLC (NASDAQ: MGTX - Get Free Report) shares saw unusually-strong trading volume on
MeiraGTx Holdings plc (MGTX) Discusses 3-Year Phase I Data on AAV-hAQP1 for Radiation-Induced Xerost
XLRP is a severe, progressive genetic eye disease causing early-onset night blindness and peripheral
LONDON and NEW YORK, April 16, 2026 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vert
LONDON and NEW YORK, April 16, 2026 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vert
LONDON and NEW YORK, April 16, 2026 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ: MGTX), a vert
Gainers Miromatrix Medical Inc. (NASDAQ: MIRO) shares climbed 230.7% to $3.3401 after United The
On Friday, 469 companies hit new 52-week lows.
On Friday, 1043 companies hit new 52-week lows.
Stocks That Hit 52-Week Lows On Wednesday
Stocks That Hit 52-Week Lows On Monday
Stocks That Hit 52-Week Lows On Thursday